It is a peptide hormone that can be used to treat adult growth hormone deficiency
Dr Cheah Ming Hann, a family physician at National University Polyclinics, said that obesity is increasingly recognised as a chronic disease and that many patients do not realise that weight regain is common once treatment stops
Professional pricing & discounts available
Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used for obesity and type 2 diabetes, yet substantial variability in weight-loss response remains poorly understood
Endocrine Practice, Volume 30, Issue 5, S70
It can, but dose increases should always be made by your provider based on your overall progress, tolerability, and current dose level